QualSec Announces NanoNose About QualSec, Inc. QualSec was formed in the Autumn of 2006 by Joel Hand and Arden Kelton, Ph.D. Mr. Hand and Dr. Kelton have been associated in various projects for more than 20 years. QualSec's operations are led by Dr. Arden A. Kelton. Dr. Kelton received his doctorate in Medical Physics from U.C.L.A. in 1969 and has been a biotechnology entrepreneur for more than 25 years. During 2002 and 2003, Dr. Kelton served as CEO for Osprey Data Systems Corp., a company that was developing an electronic nose based on thin film resonance technology. Due to lack of funding and the death of a key manager, Osprey eventually abandoned its electronic nose project. During his time with Osprey, Dr. Kelton gained knowledge of the potential business opportunities for an advanced electronic nose as well as the several problems inherent in the many different technical approaches being pursued by several academic institutions, government agencies, and industries. During 2005 and 2006, Dr. Kelton developed a general concept that could avoid many of the problems inherent in other approaches. The concept is based on his earlier work with centrifugal analyzers. This new approach, dubbed ROder technology, became the basis for the formation of QualSec Inc. by Joel Hand and Dr. Kelton in November 2006. In order to actualize the approach and solve remaining technical obstacles, QualSec subcontracted development to NAC, a technology development company owned and operated by Dr. Kevin Pegg. Dr. Pegg had previously worked with Dr. Kelton on other hi-tech developments by entrepreneurial biotech companies. He currently teaches biotechnology classes at the Advanced Technology Center in Jacksonville, part of the University of Florida, and has successfully accomplished numerous technology projects under contracts to federal and state agencies as well as major industries. In addition to his doctorate in molecular genetics, and postdoctoral training in chemical engineering, Dr. Pegg is skilled in optics, electronics, and information technology. He is also a licensed patent agent. 'QualSec is at the forefront of the olfactory development race. With our robust architecture and quality assurances, the devices that we develop surpass any other technology of their kind. 'The engine behind our success is our internally developed, proprietary ROder Technology which is implemented into powerful, yet compact air samplers. Devices that operate on ROder Technology meet the discriminatory needs of sensitivity and portability while providing real-time results with impeccable accuracy.' A device that utilises the ROder Technology will operate with four discrete functions: • Air circulation over the testing substrate • Interaction of the testing compound with airborne chemicals • Analysis of the test results • Communication of the results to the user QualSec's ROder enabled devices have applications in many high volume markets including; homeland defense, law enforcement, health care, environmental, agricultural, petrochemical, and food industries. Web: http://www.qualsensors.com |